HomeCompareATTRF vs CHD

ATTRF vs CHD: Dividend Comparison 2026

ATTRF yields 6.45% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATTRF wins by $5.92M in total portfolio value
10 years
ATTRF
ATTRF
● Live price
6.45%
Share price
$0.74
Annual div
$0.05
5Y div CAGR
57.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.95M
Annual income
$4,517,202.99
Full ATTRF calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — ATTRF vs CHD

📍 ATTRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATTRFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATTRF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATTRF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATTRF
Annual income on $10K today (after 15% tax)
$548.28/yr
After 10yr DRIP, annual income (after tax)
$3,839,622.54/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, ATTRF beats the other by $3,838,523.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATTRF + CHD for your $10,000?

ATTRF: 50%CHD: 50%
100% CHD50/50100% ATTRF
Portfolio after 10yr
$2.99M
Annual income
$2,259,247.74/yr
Blended yield
75.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

ATTRF
No analyst data
Altman Z
0.8
Piotroski
6/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATTRF buys
0
CHD buys
0
No recent congressional trades found for ATTRF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATTRFCHD
Forward yield6.45%1.27%
Annual dividend / share$0.05$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.9%23.1%
Portfolio after 10y$5.95M$26.4K
Annual income after 10y$4,517,202.99$1,292.51
Total dividends collected$5.79M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ATTRF vs CHD ($10,000, DRIP)

YearATTRF PortfolioATTRF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$11,719$1,018.52$10,856$156.32+$863.00ATTRF
2$14,300$1,761.33$11,811$195.24+$2.5KATTRF
3$18,473$3,171.80$12,883$244.38+$5.6KATTRF
4$25,813$6,046.44$14,091$306.64+$11.7KATTRF
5$40,087$12,467.87$15,463$385.88+$24.6KATTRF
6$71,467$28,573.71$17,033$487.17+$54.4KATTRF
7$151,643$75,173.51$18,843$617.36+$132.8KATTRF
8$397,644$235,385.84$20,947$785.72+$376.7KATTRF
9$1,336,336$910,856.87$23,419$1,004.91+$1.31MATTRF
10$5,947,083$4,517,202.99$26,350$1,292.51+$5.92MATTRF

ATTRF vs CHD: Complete Analysis 2026

ATTRFStock

Ascott Residence Trust (ART) is the largest hospitality trust in Asia Pacific with an asset value of S$7.2 billion as at 31 December 2020. Having listed on the Singapore Exchange Securities Trading Limited (SGX-ST) since March 2006, ART's objective is to invest primarily in incomeproducing real estate and real estate-related assets which are used or predominantly used as serviced residences, hotels, rental housing properties and other hospitality assets in any country in the world. Ascott Real Estate Investment Trust's investment mandate will include student accommodation to be effected on 27 February 2021. ART is a constituent of the FTSE EPRA Nareit Global Real Estate Index Series (Global Developed Index). ART's international portfolio comprises 86 properties with more than 16,000 units in 38 cities across 15 countries in Asia Pacific, Europe and the United States of America as at 31 December 2020. ART's properties are mostly operated under the Ascott The Residence, Somerset, Quest and Citadines brands. They are mainly located in key gateway cities such as Barcelona, Berlin, Brussels, Hanoi, Ho Chi Minh City, Jakarta, Kuala Lumpur, London, Manila, Melbourne, Munich, New York, Paris, Perth, Seoul, Shanghai, Singapore and Tokyo. ART is a stapled group comprising Ascott Real Estate Investment Trust (Ascott Reit) and Ascott Business Trust (Ascott BT). ART is managed by Ascott Residence Trust Management Limited (as manager of Ascott Reit) and Ascott Business Trust Management Pte. Ltd. (as trustee-manager of Ascott BT), both of which are wholly-owned subsidiaries of Singapore-listed CapitaLand Limited, one of Asia's largest diversified real estate groups.

Full ATTRF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this ATTRF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATTRF vs SCHDATTRF vs JEPIATTRF vs OATTRF vs KOATTRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.